Cambio CDS was awarded funding from Manchester Health innovation fund to support COVID
Industry News | June 30, 2020, 1:43 p.m.
Chest pain is one of the most common reasons for hospital admission for patients presenting at the Emergency Department, but many of these admissions could be safely avoided with improved diagnostic technology to rapidly rule out acute coronary syndromes (ACS) such as heart attack. Several clinical studies and real-world evaluations show that the Troponin-only Manchester Acute Coronary Syndrome (T-MACS) decision aid accurately identifies those at low risk of heart attack, allowing for more patients to be discharged early. The funding will be used in collaboration with e-healthcare company Cambio CDS and their Open-Standards Clinical Decision Support platform. The project will develop and pilot an online app platform for T-MACS within the workflow to allow clinicians to calculate the risk, review recommended a course of action and save data for future T-MACS related research.
- Professor Richard Body, Consultant in Emergency Medicine, Honorary Lecturer in Cardiovascular Medicine at Manchester University NHS Foundation Trust, said: “This collaboration with Cambio CDS is crucial to ensure that our current endeavours remain fully compliant with changing regulations and to make the project scalable. The platform provided by Cambio CDS would enable hospitals across the world to rapidly adopt efficient clinical pathways to care for patients with chest pain, optimising patient care and reducing unnecessary use of precious healthcare resources.”
- Dr Rong Chen, Cambio CDS CEO, said: “As Cambio CDS we are very pleased to have this opportunity to continue working with the NHS. Professor Body’s T-MACS solution is a wonderful application that has real impact for patient care and reducing unnecessary hospital admissions. We look forward to continue working with Professor Body and his team to ensure that T-MACS is seamlessly embedded in the Hospital System workflow with our EHR independent Clinical Decision Support (CDS) Solution.”
>> Back to Industry News